The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuficiencia Renal Crónica/diagnóstico,
Insuficiencia Renal Crónica/tratamiento farmacológico,
Progresión de la Enfermedad,
Triaje,
Antagonistas de Receptores de Angiotensina/uso terapéutico,
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico,
Antihipertensivos/uso terapéutico,
Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico,
Hipolipemiantes/uso terapéutico,
Gemfibrozilo/uso terapéutico,
Enfermedades Asintomáticas,
Quimioterapia Combinada,
Enfoque GRADE
